When you take drugs like azathioprine, an immunosuppressant used for autoimmune diseases and organ transplants or mercaptopurine, a chemotherapy agent for leukemia, your body breaks them down using an enzyme called TPMT, thiopurine methyltransferase, a key player in drug metabolism. But not everyone has the same amount of this enzyme. Some people have very low levels — and if they take standard doses of these drugs, they can get severely sick, even die. That’s where TPMT testing comes in. It’s not optional in many clinics anymore. It’s a blood or saliva test that tells your doctor if your body can handle these medications safely.
TPMT testing isn’t just about avoiding side effects. It’s about personalizing treatment. If your test shows you’re a slow metabolizer, your doctor can cut your dose by half or switch you to something else — no guesswork. This isn’t theoretical. Studies show that patients who get tested before starting azathioprine have far fewer cases of life-threatening low white blood cell counts. The test is quick, cheap, and often covered by insurance. Yet, many people still start these drugs without it. Why? Because it’s not always offered. If you’re prescribed azathioprine, mercaptopurine, or even thioguanine, ask: "Has my TPMT been checked?" If not, push for it. This isn’t a luxury. It’s a safety net.
TPMT testing connects to bigger ideas in medicine: genetic differences, drug interactions, and personalized care. People with low TPMT activity often react badly to other drugs too, especially those processed by similar liver pathways. It’s also linked to how your body handles other immune drugs and even some cancer treatments. The test doesn’t just protect you from one drug — it helps your whole treatment plan stay on track. Below, you’ll find real-world guides on how this testing affects prescriptions, what to do if you’ve had bad reactions before, and how to talk to your doctor about genetic risks. These aren’t theory pieces. They’re from people who’ve been there — and learned the hard way.
Azathioprine is a cost-effective immunosuppressant, but without TPMT and NUDT15 genetic testing, it can cause life-threatening drops in blood cell counts. Learn how testing prevents severe side effects and why it's essential before starting treatment.